Aniela Montserrat Silva Nolasco | Pharmaceutical Chemistry | Excellence in Research Award

Published on by Top Pharmaceutical

Excellence in Research Award


Aniela Montserrat Silva Nolasco

Universidad de Castilla-La Mancha, Spain


Aniela Montserrat Silva Nolasco
Affiliation Universidad de Castilla-La Mancha
Country Spain
Scopus ID
57221107566
Documents 21
Citations 23
h-index 2
Subject Area Pharmaceutical Chemistry
Event International Top Pharmaceutical Awards

Aniela Montserrat Silva Nolasco is a pharmaceutical science researcher associated with Universidad de Castilla-La Mancha, Spain. Her academic profile demonstrates research engagement in molecular pharmacology, pharmaceutical chemistry, cancer biology, and bioactive therapeutic compounds. Published studies associated with her scholarly work examine anticancer properties of argentatins, immunomodulatory activity, and translational therapeutic applications in oncology-related biomedical sciences.[1] Her research contributions are indexed through recognized academic databases including Scopus and ORCID, supporting international visibility and scientific dissemination within pharmaceutical and biomedical research communities.[2]

Abstract

This article summarizes the academic contributions and pharmaceutical research activities of Aniela Montserrat Silva Nolasco. The profile reflects scholarly involvement in cancer biology, molecular pharmacology, pharmaceutical chemistry, and translational therapeutic research involving argentatin compounds and related bioactive agents.[3] Indexed publications, DOI-linked research outputs, and collaborative scientific studies contribute to the researcher’s academic visibility within pharmaceutical and biomedical sciences.[4]

Keywords

Pharmaceutical Chemistry, Molecular Pharmacology, Anticancer Research, Argentatins, Cancer Biology, Translational Medicine, Immunomodulation, Biomedical Sciences, Oncology Research, Therapeutic Compounds.

Introduction

Pharmaceutical research associated with molecular therapeutics and cancer-related biomedical investigations continues to contribute substantially to contemporary translational medicine. Current scientific developments increasingly emphasize naturally derived compounds with potential therapeutic applications against tumor progression and immune dysregulation.[5] Research contributions associated with Aniela Montserrat Silva Nolasco demonstrate participation in this evolving pharmaceutical research landscape through investigations involving argentatins and cellular pharmacological mechanisms.[6]

Research Profile

The academic profile of Aniela Montserrat Silva Nolasco includes affiliations with Universidad de Castilla-La Mancha and previous research and educational activities associated with pharmaceutical and molecular sciences. Her scholarly background includes pharmaceutical biology, cellular pharmacology, and laboratory-based biomedical investigations relevant to therapeutic development and oncology-focused pharmaceutical sciences.[2]

The Scopus profile linked to the researcher identifies indexed publication activity, citation tracking, and collaborative research participation within pharmaceutical and biomedical disciplines. These indicators support measurable academic visibility and ongoing scholarly communication across internationally indexed scientific platforms.[1]

Research Contributions

Research contributions associated with Aniela Montserrat Silva Nolasco include investigations on argentatin compounds and their biological activity in cancer-related cellular environments. Published studies report antimigratory and antiangiogenic effects alongside analyses of long-term resistance induction associated with argentatin A and argentatin B.[3]

Additional scientific contributions address immunomodulatory activity isolated from guayule-derived compounds and synergistic therapeutic interactions involving 5-fluorouracil in colorectal cancer cell models. These studies contribute to broader translational pharmaceutical research exploring molecular therapeutic strategies in oncology-related biomedical sciences.[4]

Publications

The publication profile associated with Aniela Montserrat Silva Nolasco includes peer-reviewed research outputs indexed through recognized scientific databases. DOI-linked publications contribute to scholarly accessibility, research transparency, and international academic dissemination within pharmaceutical chemistry and molecular biomedical sciences.[3][4]

DOI-linked publications facilitate long-term accessibility and citation reliability within digital academic infrastructures. The use of persistent identifiers further supports research transparency, discoverability, and scholarly preservation across multidisciplinary scientific environments.[3]

Research Impact

Research impact is commonly evaluated using publication visibility, citation performance, indexed dissemination, and scholarly engagement across scientific communities. The researcher’s profile demonstrates documented participation in peer-reviewed pharmaceutical and biomedical research activities through Scopus-indexed publications and DOI-associated scholarly outputs.[1]

The available citation indicators and publication metrics support measurable academic relevance within specialized pharmaceutical chemistry and translational biomedical research domains. Continued scientific dissemination and collaborative publication activity may further strengthen long-term academic visibility and research influence.[2]

Award Suitability

The research activities and scholarly outputs associated with Aniela Montserrat Silva Nolasco align with the objectives of the International Top Pharmaceutical Awards through contributions to pharmaceutical chemistry, cancer-related therapeutic investigations, and molecular biomedical sciences.[6] The profile reflects participation in interdisciplinary scientific studies relevant to pharmaceutical innovation and translational therapeutic development.[3]

Conclusion

Aniela Montserrat Silva Nolasco has contributed to pharmaceutical and biomedical research through studies involving anticancer compounds, immunomodulatory activity, and molecular therapeutic investigations. Her academic profile demonstrates scholarly engagement within pharmaceutical chemistry and translational medicine, supported by indexed publications, collaborative research contributions, and DOI-linked scientific dissemination.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Aniela Montserrat Silva Nolasco, Author ID 57221107566. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57221107566
  2. ORCID. (2026). Aniela M. Silva-Nolasco ORCID profile, affiliations, and academic activities.https://orcid.org/0000-0002-2134-7551
  3. Silva-Nolasco, A. M., Galvez, B. G., de la Cruz-Morcillo, M. A., & Carmona, M. (2026). Differential anti-cancer effects of argentatin A and B: antimigratory, antiangiogenic, and long-term resistance induction. Industrial Crops and Products.https://doi.org/10.1016/j.indcrop.2026.123255
  4. Silva-Nolasco, A. M., Singh, N., de la Cruz-Morcillo, M. A., García-Martínez, M. M., Zalacain, A., Gálvez, B. G., & Carmona, M. (2024). Immunomodulatory activity of argentatins A and B isolated from guayule. PLOS ONE.https://doi.org/10.1371/journal.pone.0304713
  5. Sánchez‐Olivares, P., Silva‐Nolasco, A. M., de la Cruz‐Morcillo, M. A., García‐Martínez, M. M., Pinedo‐Serrano, A., Carmona, M., & Galán‐Moya, E. M. (2024). Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models. Journal of Cellular and Molecular Medicine.https://doi.org/10.1111/jcmm.70294

Srinivasaprabhu Natarajan | Pharmaceutical Biotechnology | Top Pharmaceutical Scientist Award

Published on by Top Pharmaceutical

Top Pharmaceutical Scientist Award

Srinivasaprabhu Natarajan
Bal Pharma Limited, India
Academic Profile
Affiliation Bal Pharma Limited
Country India
Scopus ID Not Available
Documents 8
Citations 267
h-index 7
Subject Area Pharmaceutical Biotechnology
Event
International Top Pharmaceutical Awards

The Top Pharmaceutical Scientist Award recognition profile of Srinivasaprabhu Natarajan presents a concise academic overview of scholarly contributions associated with pharmaceutical biotechnology and applied pharmaceutical sciences. Affiliated with Bal Pharma Limited, India, the researcher has contributed to scientific publications with measurable citation impact and interdisciplinary relevance within pharmaceutical and biomedical domains.[1] The profile demonstrates sustained engagement in scientific dissemination, collaborative publication activity, and research visibility through recognized scholarly indexing systems.[2]

Abstract

This article summarizes the academic and research profile of Srinivasaprabhu Natarajan within the field of pharmaceutical biotechnology. The profile reflects documented scholarly activity measured through publications, citations, and bibliometric indicators. Research outputs associated with pharmaceutical sciences, drug formulation studies, biotechnology applications, and interdisciplinary biomedical research contribute to the overall academic visibility of the researcher.[1] The profile also highlights recognition suitability within international pharmaceutical award evaluation frameworks.[1]

Keywords

  • Pharmaceutical Biotechnology
  • Drug Development
  • Citation Analysis
  • Research Evaluation
  • Academic Recognition
  • Biomedical Sciences
  • Top Pharmaceutical Scientist Award

Introduction

Pharmaceutical biotechnology continues to play a significant role in modern healthcare innovation through advancements in therapeutics, drug delivery systems, and translational biomedical research. Researchers contributing to this domain are frequently evaluated using bibliometric indicators such as publication volume, citation influence, and h-index performance.[2] Academic recognition initiatives, including international pharmaceutical award platforms, often utilize these indicators as part of broader qualitative and quantitative assessment criteria.[1]

Srinivasaprabhu Natarajan has demonstrated scholarly participation through publications associated with pharmaceutical sciences and biotechnology-oriented research themes. The available citation metrics indicate moderate research visibility and measurable scientific engagement within indexed academic ecosystems.[1]

Research Profile

The research profile of Srinivasaprabhu Natarajan reflects involvement in pharmaceutical and biotechnology-oriented scientific studies with documented publication activity. Based on publicly available academic indexing information, the profile includes eight scholarly documents with a cumulative citation count of 267 and an h-index value of 7.[1]

The research focus appears aligned with pharmaceutical biotechnology applications, including analytical methodologies, pharmaceutical formulations, biomedical innovation, and interdisciplinary scientific approaches relevant to healthcare research.[2] Citation performance suggests continued relevance of published works within the scientific community.

Research Contributions

Research contributions associated with the profile include participation in scientific investigations related to pharmaceutical sciences and biotechnology-based applications. The scholarly work demonstrates engagement with contemporary research themes involving pharmaceutical analysis, biomedical formulations, and therapeutic development.[2]

  • Contribution to pharmaceutical biotechnology research methodologies.
  • Participation in interdisciplinary pharmaceutical and biomedical studies.
  • Scientific publication dissemination through indexed academic platforms.
  • Research collaboration supporting citation visibility and scholarly communication.

Publications

The publication record associated with the researcher demonstrates measurable scientific productivity in pharmaceutical and biotechnology-related areas. Indexed scholarly publications contribute to the citation profile and indicate engagement with peer-reviewed academic dissemination systems.[1]

  1. Pharmaceutical biotechnology and formulation-oriented scientific studies.
  2. Research publications involving analytical and biomedical methodologies.
  3. Collaborative publications contributing to citation impact and scholarly indexing.
  4. Scientific outputs referenced within pharmaceutical research ecosystems.

Representative DOI-linked academic resources and publication indexing systems contribute to the visibility of the researcher’s scholarly output.[2]

Research Impact

Bibliometric indicators are commonly used to evaluate research visibility and scholarly influence. The available profile metrics indicate citation activity across indexed publications with measurable academic engagement. An h-index value of 7 reflects sustained citation performance relative to the documented publication count.[2]

The citation record further demonstrates that the researcher’s publications have contributed to ongoing scientific discussions within pharmaceutical and biomedical research communities. Such indicators are frequently considered during academic recognition and award evaluations.[1]

Award Suitability

Based on the available scholarly metrics and publication activity, Srinivasaprabhu Natarajan demonstrates characteristics commonly associated with eligibility for pharmaceutical research recognition programs. The profile reflects documented academic engagement, measurable citation influence, and sustained scientific contribution within the pharmaceutical biotechnology domain.[1]

The combination of publication activity, citation visibility, and interdisciplinary research relevance supports suitability for consideration within international pharmaceutical recognition platforms and scientific excellence awards.[1]

Conclusion

The academic profile of Srinivasaprabhu Natarajan illustrates sustained participation in pharmaceutical biotechnology research through scholarly publications and citation-based academic visibility. The documented metrics indicate meaningful scientific engagement and continued contribution to pharmaceutical and biomedical research discussions.[1] The profile aligns with professional standards commonly considered in pharmaceutical award evaluations and international academic recognition initiatives.[1]

References

  1. Google Scholar. (n.d.). Scholar profile of Srinivasaprabhu Natarajan. Google Scholar.https://scholar.google.com/citations?user=4GdatCMAAAAJ&hl=en
  2. National Center for Biotechnology Information. (n.d.). Pharmaceutical biotechnology and biomedical research methodologies.https://www.ncbi.nlm.nih.gov/

Evgeni Grigorov | Pharmacovigilance | OncologyPharmaOnc Trailblazer Award

Published on by Top Pharmaceutical
After Completing the Registration Process, your Biography will be displayed here.

Register by using your Entry ID: 2636

Register Here

Palma Rocchi | Nanomedicine | Research Excellence Award

Published on by Top Pharmaceutical

Prof. Dr. Palma Rocchi | Nanomedicine | Research Excellence Award

Director | Aix-Marseille University | France

Prof. Dr. Palma Rocchi is a distinguished professor at Aix-Marseille University, France, specializing in biomedical and cancer research. She holds advanced degrees in life sciences with a focus on molecular and cellular biology, forming a strong academic foundation for her scientific career. Her professional experience includes leading multidisciplinary research teams, contributing to innovative projects, and playing key roles in academic and institutional development. Her research primarily focuses on cancer biology, therapeutic targets, and translational medicine, with a substantial body of highly cited publications demonstrating significant contributions to scientific advancement. She has been actively involved in editorial responsibilities, peer review activities, and international research collaborations, reflecting her leadership within the scientific community. Her achievements have been recognized through multiple awards and honors, along with memberships in prominent scientific organizations, highlighting her commitment to excellence, innovation, and impactful research in her field.

Citation Metrics (Google Scholar)

8760
6000
3000
1000
0

8760

77

49

Citations

i10-index

h-index


Top 5 Featured Publications

 

Gerassimos Pangalis | Haematology | Research Excellence Award

Published on by Top Pharmaceutical

Prof. Gerassimos Pangalis | Haematology | Research Excellence Award

Professor | Athens Medical Center |Greece

Prof. Gerassimos Pangalis is a distinguished hematologist at Athens Medical Center, Psychikon Branch, Greece, recognized for his expertise in hematologic malignancies and clinical research. He earned advanced medical degrees with specialization in internal medicine and hematology, followed by extensive academic training in diagnostic and therapeutic hematology. Over his career, he has held senior clinical and academic positions, leading multidisciplinary teams and contributing to the development of innovative treatment protocols and translational research initiatives. His research focuses on lymphoproliferative disorders, particularly chronic lymphocytic leukemia and related malignancies, with numerous high-impact publications that have significantly influenced clinical practice and patient management strategies. Prof. Pangalis has also played key roles in collaborative research networks and clinical trials, advancing evidence-based hematology. He serves on editorial boards of reputable scientific journals and is an active member of leading professional organizations in hematology and oncology. His contributions have been recognized through multiple prestigious awards and honors, reflecting his commitment to advancing research, education, and excellence in clinical care.

Citation Metrics (Google Scholar)

10761
8000
5000
2000
0

10761

154

52

Citations

i10-index

h-index


Top 5 Featured Publications